This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2194) e-Mental Health and Cyberpsychology (1388) Depression and Mood Disorders; Suicide Prevention (1273) Diagnostic Tools in Mental Health (220) Machine Learning (1373) Anxiety and Stress Disorders (1002) Methods and New Tools in Mental Health Research (424) Transdiagnostic Mental Health Interventions (120)

Published on in Vol 5, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27908, first published .
Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation Study

Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation Study

Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation Study

Authors of this article:

Nayra A Martin-Key1 Author Orcid Image ;   Dan-Mircea Mirea1, 2 Author Orcid Image ;   Tony Olmert1, 3 Author Orcid Image ;   Jason Cooper1, 4 Author Orcid Image ;   Sung Yeon Sarah Han1 Author Orcid Image ;   Giles Barton-Owen5 Author Orcid Image ;   Lynn Farrag5 Author Orcid Image ;   Emily Bell5 Author Orcid Image ;   Pawel Eljasz1 Author Orcid Image ;   Daniel Cowell5, 6 Author Orcid Image ;   Jakub Tomasik1 Author Orcid Image ;   Sabine Bahn1, 5 Author Orcid Image
Article Authors Cited by (1) Tweetations (4) Metrics

Nayra A Martin-Key   1 , PhD ;   Dan-Mircea Mirea   1, 2 , MSc ;   Tony Olmert   1, 3 , MPhil ;   Jason Cooper   1, 4 , PhD ;   Sung Yeon Sarah Han   1 , PhD ;   Giles Barton-Owen   5 , MA ;   Lynn Farrag   5 , BSc ;   Emily Bell   5 , BA ;   Pawel Eljasz   1 ;   Daniel Cowell   5, 6 , BSc ;   Jakub Tomasik   1 , PhD ;   Sabine Bahn   1, 5 , MRCPsych, MD, PhD

1 Cambridge Centre for Neuropsychiatric Research, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom

2 Princeton Neuroscience Institute, Princeton University, Princeton, NJ, United States

3 UC San Diego School of Medicine, University of California, San Diego, CA, United States

4 Owlstone Medical Ltd, Cambridge, United Kingdom

5 Psyomics Ltd, Cambridge, United Kingdom

6 Sentinel Oncology Ltd, Cambridge, United Kingdom

Corresponding Author:

  • Sabine Bahn, MRCPsych, MD, PhD
  • Cambridge Centre for Neuropsychiatric Research
  • Department of Chemical Engineering and Biotechnology
  • University of Cambridge
  • Philippa Fawcett Drive
  • Cambridge, CB3 0AS
  • United Kingdom
  • Phone: 44 1223 334151
  • Email: sb209@cam.ac.uk